Form 4: Procter & Gamble Executive Jennifer L. Davis Reports Stock Award and Disposals

Jennifer L. Davis, CEO Health Care at Procter & Gamble, reports acquisition of shares via stock award and disposals through retirement plan.

Summary

• On August 19, 2024, Jennifer L. Davis, CEO Health Care at Procter & Gamble, reported transactions involving Procter & Gamble common stock.
• Davis acquired 15,971 shares of common stock through a stock award at a price of $0 per share.
• Davis disposed of 14,498.0702 shares of common stock indirectly through a retirement plan trustee.
• Following these transactions, Davis directly owns 63,437.2367 shares of Procter & Gamble common stock.
• The stock award was granted pursuant to the issuer's 2019 Stock and Incentive Compensation Plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports transactions without expressing any positive or negative outlook.

Positives

• The acquisition of shares via stock award indicates confidence in the company's future performance.

Negatives

• The disposal of shares, even if through a retirement plan, could be interpreted negatively by some investors, although it's a common practice.

Risks

• There are no specific risks mentioned in this document.
• However, insider transactions are always subject to scrutiny and potential legal challenges if not conducted properly.

Industry Context

Insider trading activity is closely monitored in the consumer goods industry, as it can provide insights into the company's performance and future prospects. Form 4 filings are a routine part of this monitoring process.

Comparison to Industry Standards

• Form 4 filings are standard practice for executives at publicly traded companies like Procter & Gamble, similar to filings made by executives at comparable companies such as Unilever, Nestle, and Johnson & Johnson.
• The reporting requirements are governed by SEC regulations and are consistent across the industry.

Stakeholder Impact

• The transactions may have a minor impact on shareholders' perception of the company, but are unlikely to significantly affect other stakeholders.

Key Dates